Substance / Medication

Naratriptan

Overview

Active Ingredient
naratriptan
RxNorm CUI
141366

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Brandes Jan Lewis, Smith Timothy, Diamond Merle et al. · Headache · 2007
PMID: 17578540Trial
Naratriptan in the short-term prophylaxis of pure menstrual migraine.
Moschiano F, Allais G, Grazzi L et al. · Neurol Sci · 2005
PMID: 15926020Trial
The combination of naratriptan and prochlorperazine in migraine treatment.
Tietjen Gretchen E, Athanas Kathy, Utley Christine et al. · Headache · 2005
PMID: 15953309Trial
Efficacy of oral naratriptan in the treatment of menstrually related migraine.
Massiou H, Jamin C, Hinzelin G et al. · Eur J Neurol · 2005
PMID: 16190915Trial
Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database.
Christoph-Diener Hans, Ferrari Michel, Mansbach Hank et al. · Neurology · 2004
PMID: 15304585Trial
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
Garcia-Ramos G, MacGregor E A, Hilliard B et al. · Cephalalgia · 2003
PMID: 14616928Trial
Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine.
Christensen M L, Eades S K, Fuseau E et al. · J Clin Pharmacol · 2001
PMID: 11210397Trial
Effect of naratriptan on myocardial blood flow and coronary vasodilator reserve in migraineurs.
Gnecchi-Ruscone T, Bernard X, Pierre P et al. · Neurology · 2000
PMID: 10891912Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Naratriptan (substance)
SNOMED CT
363571003
UMLS CUI
C0540623
RxNorm CUI
141366

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.